Nanologica AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NICA.ST research report →
Companywww.nanologica.com
Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography.
- CEO
- Andreas Bhagwani
- IPO
- 2015
- Employees
- 16
- HQ
- Södertälje, SE
Price Chart
Valuation
- Market Cap
- $64.95M
- P/E
- 2.64
- P/S
- 2.04
- P/B
- 0.68
- EV/EBITDA
- -4.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -105.45%
- Op Margin
- -145.98%
- Net Margin
- 78.97%
- ROE
- 47.40%
- ROIC
- -21.46%
Growth & Income
- Revenue
- $21.13M · 45.32%
- Net Income
- $-51,289,000 · 21.85%
- EPS
- $-0.58 · 56.06%
- Op Income
- $-46,992,000
- FCF YoY
- 49.83%
Performance & Tape
- 52W High
- $2.25
- 52W Low
- $0.33
- 50D MA
- $0.49
- 200D MA
- $0.83
- Beta
- -0.12
- Avg Volume
- 3.23M
Get TickerSpark's AI analysis on NICA.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NICA.ST Coverage
We haven't published any research on NICA.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NICA.ST Report →